233 related articles for article (PubMed ID: 10982389)
1. Exposure at the cell surface is required for gas3/PMP22 To regulate both cell death and cell spreading: implication for the Charcot-Marie-Tooth type 1A and Dejerine-Sottas diseases.
Brancolini C; Edomi P; Marzinotto S; Schneider C
Mol Biol Cell; 2000 Sep; 11(9):2901-14. PubMed ID: 10982389
[TBL] [Abstract][Full Text] [Related]
2. Glycan-independent role of calnexin in the intracellular retention of Charcot-Marie-tooth 1A Gas3/PMP22 mutants.
Fontanini A; Chies R; Snapp EL; Ferrarini M; Fabrizi GM; Brancolini C
J Biol Chem; 2005 Jan; 280(3):2378-87. PubMed ID: 15537650
[TBL] [Abstract][Full Text] [Related]
3. Rho-dependent regulation of cell spreading by the tetraspan membrane protein Gas3/PMP22.
Brancolini C; Marzinotto S; Edomi P; Agostoni E; Fiorentini C; Müller HW; Schneider C
Mol Biol Cell; 1999 Jul; 10(7):2441-59. PubMed ID: 10397775
[TBL] [Abstract][Full Text] [Related]
4. Apoptotic phenotype induced by overexpression of wild-type gas3/PMP22: its relation to the demyelinating peripheral neuropathy CMT1A.
Fabbretti E; Edomi P; Brancolini C; Schneider C
Genes Dev; 1995 Aug; 9(15):1846-56. PubMed ID: 7649472
[TBL] [Abstract][Full Text] [Related]
5. Many facets of the peripheral myelin protein PMP22 in myelination and disease.
Naef R; Suter U
Microsc Res Tech; 1998 Jun; 41(5):359-71. PubMed ID: 9672419
[TBL] [Abstract][Full Text] [Related]
6. Charcot-Marie-Tooth disease and related inherited neuropathies.
Murakami T; Garcia CA; Reiter LT; Lupski JR
Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
[TBL] [Abstract][Full Text] [Related]
7. Alterations in the Arf6-regulated plasma membrane endosomal recycling pathway in cells overexpressing the tetraspan protein Gas3/PMP22.
Chies R; Nobbio L; Edomi P; Schenone A; Schneider C; Brancolini C
J Cell Sci; 2003 Mar; 116(Pt 6):987-99. PubMed ID: 12584243
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of a new member of the gas3/PMP22 gene family in C. elegans.
Agostoni E; Gobessi S; Brancolini C; Schneider C
Gene; 1999 Jul; 234(2):267-74. PubMed ID: 10395899
[TBL] [Abstract][Full Text] [Related]
9. Dejerine-Sottas syndrome associated with point mutation in the peripheral myelin protein 22 (PMP22) gene.
Roa BB; Dyck PJ; Marks HG; Chance PF; Lupski JR
Nat Genet; 1993 Nov; 5(3):269-73. PubMed ID: 8275092
[TBL] [Abstract][Full Text] [Related]
10. Clinical implications of peripheral myelin protein 22 for nerve compression and neural regeneration: a review.
Hui-Chou HG; Hashemi SS; Hoke A; Dellon AL
J Reconstr Microsurg; 2011 Jan; 27(1):67-74. PubMed ID: 20976668
[TBL] [Abstract][Full Text] [Related]
11. Four novel point mutations in the PMP22 gene with phenotypes of HNPP and Dejerine-Sottas neuropathy.
Brožková D; Mazanec R; Rychlý Z; Haberlová J; Böhm J; Staněk J; Plevová P; Lisoňová J; Sabová J; Sakmaryová I; Seeman P
Muscle Nerve; 2011 Nov; 44(5):819-22. PubMed ID: 22006697
[TBL] [Abstract][Full Text] [Related]
12. PMP22 related congenital hypomyelination neuropathy.
Fabrizi GM; Simonati A; Taioli F; Cavallaro T; Ferrarini M; Rigatelli F; Pini A; Mostacciuolo ML; Rizzuto N
J Neurol Neurosurg Psychiatry; 2001 Jan; 70(1):123-6. PubMed ID: 11118262
[TBL] [Abstract][Full Text] [Related]
13. PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and Hereditary Neuropathy with liability to Pressure Palsies.
van Paassen BW; van der Kooi AJ; van Spaendonck-Zwarts KY; Verhamme C; Baas F; de Visser M
Orphanet J Rare Dis; 2014 Mar; 9():38. PubMed ID: 24646194
[TBL] [Abstract][Full Text] [Related]
14. Ultrastructural distribution of PMP22 in Charcot-Marie-Tooth disease type 1A.
Haney C; Snipes GJ; Shooter EM; Suter U; Garcia C; Griffin JW; Trapp BD
J Neuropathol Exp Neurol; 1996 Mar; 55(3):290-9. PubMed ID: 8786387
[TBL] [Abstract][Full Text] [Related]
15. Genetic epidemiology of Charcot-Marie-Tooth disease.
Braathen GJ
Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
[TBL] [Abstract][Full Text] [Related]
16. Overloaded endoplasmic reticulum-Golgi compartments, a possible pathomechanism of peripheral neuropathies caused by mutations of the peripheral myelin protein PMP22.
D'Urso D; Prior R; Greiner-Petter R; Gabreëls-Festen AA; Müller HW
J Neurosci; 1998 Jan; 18(2):731-40. PubMed ID: 9425015
[TBL] [Abstract][Full Text] [Related]
17. Peripheral myelin protein 22 modulates store-operated calcium channel activity, providing insights into Charcot-Marie-Tooth disease etiology.
Vanoye CG; Sakakura M; Follis RM; Trevisan AJ; Narayan M; Li J; Sanders CR; Carter BD
J Biol Chem; 2019 Aug; 294(32):12054-12065. PubMed ID: 31213528
[TBL] [Abstract][Full Text] [Related]
18. Rer1 and calnexin regulate endoplasmic reticulum retention of a peripheral myelin protein 22 mutant that causes type 1A Charcot-Marie-Tooth disease.
Hara T; Hashimoto Y; Akuzawa T; Hirai R; Kobayashi H; Sato K
Sci Rep; 2014 Nov; 4():6992. PubMed ID: 25385046
[TBL] [Abstract][Full Text] [Related]
19. Schwann cell differentiation in Charcot-Marie-Tooth disease type 1A (CMT1A): normal number of myelinating Schwann cells in young CMT1A patients and neural cell adhesion molecule expression in onion bulbs.
Hanemann CO; Gabreëls-Festen AA; Stoll G; Müller HW
Acta Neuropathol; 1997 Oct; 94(4):310-5. PubMed ID: 9341930
[TBL] [Abstract][Full Text] [Related]
20. Correlation between the histopathologic, genotypic, and phenotypic features of hereditary peripheral neuropathies in childhood.
Ouvrier R
J Child Neurol; 1996 Mar; 11(2):133-46. PubMed ID: 8881991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
